Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MOTS-C Purity: Research-Grade vs Pharmaceutical-Grade Standards

HPLC Purity 98.0–99.5% ≥99.0% MOTS-C at 98% contains ~2% deletion sequences that compete for receptor binding without activating AMPK Endotoxin Level <10 EU/mg <1 EU/mg In vivo studies require low endotoxin to avoid confounding inflammatory responses Sterility

This comparison does not assign a generated winner or score.

  • HPLC Purity
  • 98.0–99.5%
  • ≥99.0%
  • MOTS-C at 98% contains ~2% deletion sequences that compete for receptor binding without activating AMPK
  • Endotoxin Level
  • <10 EU/mg
  • <1 EU/mg
  • In vivo studies require low endotoxin to avoid confounding inflammatory responses
  • Sterility Testing
  • Not required
  • USP sterility test required
  • Critical for any protocol involving injection or cell culture
  • Heavy Metals
  • Not specified
  • <10 ppm lead, <5 ppm arsenic
  • Trace metal contamination affects mitochondrial assays directly
  • Peptide Content
  • 75–90% by weight
  • ≥95% by weight
  • A '5mg' vial at 75% content delivers only 3.75mg MOTS-C
  • Bottom Line
  • Sufficient for cell culture and mechanistic studies; unsuitable for human or animal models without additional verification
  • Required for any clinical or regulatory submission; cost premium justified only when data must meet FDA or EMA standards
More references

Related material